Search research articles
Contact Us
Filters
Showing results (71-80 of 183) with videos related to
Page
of 19
Sort By:
British Journal of Haematology
|
October 27, 2023
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada
Inna Y Gong, Anca Prica, Zharmaine Ante, et al.
Haematologica
|
May 13, 2010
Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma
Noemi Puig, Melania Pintilie, Tara Seshadri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2016
Phase I Study of Inotuzumab Ozogamicin Combined with R-CVP for Relapsed/Refractory CD22+ B-cell Non-Hodgkin Lymphoma
Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake, et al.
Haematologica
|
November 4, 2017
A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma
Mark Bosch, Ariz Akhter, Bingshu E Chen, et al.
Cancer Cytopathology
|
March 27, 2015
Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B-cell non-Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation
Gilda da Cunha Santos, Mauro Ajaj Saieg, Hyang Mi Ko, et al.
Blood Neoplasia
|
August 4, 2025
Outcomes and factors influencing survival in patients with diffuse large B-cell lymphoma: a population-based analysis
Inna Y Gong, Michael Crump, Anca Prica, et al.
The Oncologist
|
May 25, 2023
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial
Arjun Gupta, Annette E Hay, Michael Crump, et al.
Blood
|
March 23, 2012
A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies
Laurie H Sehn, Sarit E Assouline, Douglas A Stewart, et al.
Leukemia & Lymphoma
|
July 17, 2012
Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital
Maryse Bernard, Richard W Tsang, Lisa W Le, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2012
Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant
Jayant S Goda, Christine Massey, John Kuruvilla, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 183) with videos related to
Sort By:
Page
of 19
British Journal of Haematology
|
October 27, 2023
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada
Inna Y Gong, Anca Prica, Zharmaine Ante, et al.
Haematologica
|
May 13, 2010
Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma
Noemi Puig, Melania Pintilie, Tara Seshadri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2016
Phase I Study of Inotuzumab Ozogamicin Combined with R-CVP for Relapsed/Refractory CD22+ B-cell Non-Hodgkin Lymphoma
Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake, et al.
Haematologica
|
November 4, 2017
A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma
Mark Bosch, Ariz Akhter, Bingshu E Chen, et al.
Cancer Cytopathology
|
March 27, 2015
Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B-cell non-Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation
Gilda da Cunha Santos, Mauro Ajaj Saieg, Hyang Mi Ko, et al.
Blood Neoplasia
|
August 4, 2025
Outcomes and factors influencing survival in patients with diffuse large B-cell lymphoma: a population-based analysis
Inna Y Gong, Michael Crump, Anca Prica, et al.
The Oncologist
|
May 25, 2023
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial
Arjun Gupta, Annette E Hay, Michael Crump, et al.
Blood
|
March 23, 2012
A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies
Laurie H Sehn, Sarit E Assouline, Douglas A Stewart, et al.
Leukemia & Lymphoma
|
July 17, 2012
Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital
Maryse Bernard, Richard W Tsang, Lisa W Le, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2012
Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant
Jayant S Goda, Christine Massey, John Kuruvilla, et al.
Page
of 19